These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33356982)

  • 21. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function--a 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension.
    Liu ZM; Ho SC; Chen YM; Tomlinson B; Ho S; To K; Woo J
    Eur J Clin Nutr; 2015 Oct; 69(10):1161-8. PubMed ID: 25782428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of green kiwifruit combined with isoflavones on equol production, bone turnover and gut microflora in healthy postmenopausal women.
    Kruger MC; Middlemiss C; Katsumata S; Tousen Y; Ishimi Y
    Asia Pac J Clin Nutr; 2018; 27(2):347-358. PubMed ID: 29384322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women.
    Ishiwata N; Melby MK; Mizuno S; Watanabe S
    Menopause; 2009; 16(1):141-8. PubMed ID: 19131846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women.
    Leonard LM; Choi MS; Cross TL
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
    Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Dietary Isoflavone Supplementation on the Fecal Microbiota and Its Metabolites in Postmenopausal Women.
    Guadamuro L; Azcárate-Peril MA; Tojo R; Mayo B; Delgado S
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of whole soy and isoflavones daidzein on bone turnover and inflammatory markers: a 6-month double-blind, randomized controlled trial in Chinese postmenopausal women who are equol producers.
    Liu ZM; Chen B; Li S; Li G; Zhang D; Ho SC; Chen YM; Ma J; Qi H; Ling WH
    Ther Adv Endocrinol Metab; 2020; 11():2042018820920555. PubMed ID: 32595918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of isolated isoflavone supplementation on ABCA1-dependent cholesterol efflux potential in postmenopausal women.
    Badeau R; Jauhiainen M; Metso J; Nikander E; Tikkanen MJ; Ylikorkala O; Mikkola TS
    Menopause; 2007; 14(2):293-9. PubMed ID: 17224860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Equol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.
    Tseng M; Byrne C; Kurzer MS; Fang CY
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1975-83. PubMed ID: 24019393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural S-equol decreases bone resorption in postmenopausal, non-equol-producing Japanese women: a pilot randomized, placebo-controlled trial.
    Tousen Y; Ezaki J; Fujii Y; Ueno T; Nishimuta M; Ishimi Y
    Menopause; 2011 May; 18(5):563-74. PubMed ID: 21252728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cross-sectional study of equol producer status and self-reported vasomotor symptoms.
    Newton KM; Reed SD; Uchiyama S; Qu C; Ueno T; Iwashita S; Gunderson G; Fuller S; Lampe JW
    Menopause; 2015 May; 22(5):489-95. PubMed ID: 25380274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women.
    Weickert MO; Reimann M; Otto B; Hall WL; Vafeiadou K; Hallund J; Ferrari M; Talbot D; Branca F; Bügel S; Williams CM; Zunft HJ; Koebnick C
    J Negat Results Biomed; 2006 Aug; 5():11. PubMed ID: 16907966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 6-month effect of whole soy and purified isoflavones daidzein on thyroid function-A double-blind, randomized, placebo controlled trial among Chinese equol-producing postmenopausal women.
    Liu ZM; Zhang D; Li G; Ho SC; Chen YM; Ma J; Huang Q; Li S; Ling WH
    Phytother Res; 2021 Oct; 35(10):5838-5846. PubMed ID: 34494323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial.
    Chilibeck PD; Vatanparast H; Pierson R; Case A; Olatunbosun O; Whiting SJ; Beck TJ; Pahwa P; Biem HJ
    J Bone Miner Res; 2013 Apr; 28(4):780-93. PubMed ID: 23165609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inter-relationship between diet, lifestyle habits, gut microflora, and the equol-producer phenotype: baseline findings from a placebo-controlled intervention trial.
    Yoshikata R; Myint KZ; Ohta H; Ishigaki Y
    Menopause; 2019 Mar; 26(3):273-285. PubMed ID: 30188331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey.
    Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S
    PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
    Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
    Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody-based time-resolved fluorescence immunoassays for daidzein, genistein, and equol in blood and urine: application to the Isoheart intervention study.
    Talbot DC; Ogborne RM; Dadd T; Adlercreutz H; Barnard G; Bugel S; Kohen F; Marlin S; Piron J; Cassidy A; Powell J
    Clin Chem; 2007 Apr; 53(4):748-56. PubMed ID: 17317887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.